SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
HIV REPLICATION, INHIBITION, AND RESTRICTION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
IDENTIFICATION OF HIV-1 ENV MUTATIONS THAT CONFER BROAD RESISTANCE TO ARVS IN VITRO (ABSTRACT
111)
Rachel Van Duyne
National Cancer Institute, Frederick, MD, USA
STRAIN-DEPENDENT ACTIVATION AND INHIBITION OF HIV-1 ENTRY BY A PF-68742 DIASTEREOMER (ABSTRACT
112)
Connie Ann Zhao
Dana Farber Cancer Institute, Boston, MA, USA
TRISPECIFIC ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV-1 INFECTION (ABSTRACT
113LB)
Amarendra Pegu
Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
MOLECULAR DETERMINANTS OF HIV HYPERMUTATION (ABSTRACT
114)
Diako Ebrahimi
University of Minnesota, Minneapolis, MN, USA
HIV-1 SPLICING SUPPRESSION AS A POSSIBLE THERAPEUTIC TARGET (ABSTRACT
115)
Ann Emery
University of North Carolina Chapel Hill, Durham, NC, USA
A LONG INTERNAL LOOP GOVERNS THE SENSITIVITY OF THE ANTI-HIV PROTEIN SERINC5 TO NEF (ABSTRACT
116)
Weiwei Dai
University of Massachusetts Medical School, Worcester, MA, USA
PROTECTIVE GENE EXPRESSION SIGNATURE IN RESPONSE TO RHCMV/SIV VACCINE VECTORS (ABSTRACT
117)
Michael Gale
University of Washington, Seattle, WA, USA
CROSS-SPECIES CMV VACCINATION REVEALS DETERMINANTS OF NON-CLASSICAL T CELLS (ABSTRACT
118)
Justin Greene
Oregon Health & Science University, Beaverton, OR, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
